CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 190 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.50 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,832,000 | +151.7% | 341,584 | +105.5% | 0.00% | 0.0% |
| Q4 2021 | $1,125,000 | +26.0% | 166,223 | -1.3% | 0.00% | 0.0% |
| Q3 2021 | $893,000 | -6.3% | 168,398 | +1.6% | 0.00% | 0.0% |
| Q2 2021 | $953,000 | -0.2% | 165,722 | -20.0% | 0.00% | 0.0% |
| Q1 2021 | $955,000 | +139.3% | 207,255 | +73.4% | 0.00% | – |
| Q4 2020 | $399,000 | +14.7% | 119,529 | +2.0% | 0.00% | – |
| Q3 2020 | $348,000 | -14.1% | 117,185 | +33.6% | 0.00% | – |
| Q2 2020 | $405,000 | +113.2% | 87,698 | +77.7% | 0.00% | – |
| Q1 2020 | $190,000 | -18.5% | 49,353 | -20.4% | 0.00% | – |
| Q4 2019 | $233,000 | +247.8% | 62,008 | +392.9% | 0.00% | – |
| Q3 2019 | $67,000 | -93.0% | 12,579 | -93.3% | 0.00% | -100.0% |
| Q1 2019 | $952,000 | -6.8% | 186,708 | -28.6% | 0.00% | 0.0% |
| Q4 2017 | $1,022,000 | – | 261,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |